MyStart Health vs Sprout Health

Choose MyStart Health if: You want blood work, prescriptions and shipping bundled into one price and accept $217-267/month for it, which starts above both of Sprout's entry prices, with essentially equivalent service quality and medical oversight, can self-manage nutrition and lifestyle modifications independently, and decide primarily on pricing rather than meaningful service differentiation.

Choose Sprout if: You want the cheaper way in, $149/month for compounded semaglutide or $199/month for compounded tirzepatide, verified September 17, 2026, both below MyStart's $217-267. You also want the option of tirzepatide alongside semaglutide, which Sprout's listing carries and MyStart's does not. Service is near-identical between the two, so entry price and formulary are what you are actually choosing on, with your own dose the open question at both.

Bottom line: MyStart Health and Sprout represent functionally equivalent budget-tier GLP-1 weight loss platforms competing in a commoditized market segment with minimal differentiation. Both provide compounded semaglutide through basic physician consultations, limited support infrastructure and undisclosed compounding pharmacy sourcing, with Sprout also carrying tirzepatide. Sprout is the cheaper of the two to start, at $149/month for semaglutide and $199/month for tirzepatide, verified September 17, 2026, against MyStart's $217-267. MyStart's counter is the bundle: blood work, prescriptions and shipping in one price. Service quality, medical oversight and sourcing are otherwise indistinguishable. If you want comprehensive behavioral support, medical management or premium pharmaceutical quality, look at higher-tier platforms (Eden, Ro Body) despite 30-50% cost premiums. Between these two, choose on the entry price and on whether MyStart's bundled blood work is worth the difference, because the service-quality gap you might be hunting for is not there.